186 The Impact of the Act for the Development of Biotech and New Pharmaceuticals Industry on Firm Innovation in Taiwan Tillinger, J. W. 1991. An analysis of the effectiveness of the research and experimentation tax credit in a q model of valuation. Journal of the American Taxation Association, 13 (2): 1-29. Toivanen, O., and Niininen, P. 2000. Investment, R&D, subsidies, and credit constraints (HSEBA Working Paper No. W-264). Helsinki, Finland: Department of Economics MIT and Helsinki School of Economics. Trajtenberg, M. 1990. A penny for your quotes: Patent citations and the value of innovations. The RAND Journal of Economics, 21 (1): 172-187. Wallsten, S. J. 2000. The effects of government-industry R&D programs on private R&D: The case of the small business innovation research program. The RAND Journal of Economics, 31 (1): 82-100. Wernerfelt, B., and Montgomery, C. A. 1988. Tobin’s q and the importance of focus in firm performance. The American Economic Review, 78 (1): 246-250. Winston, C. 2006. Government Failure versus Market Failure: Microeconomics Policy Research and Government Performance. Washington, DC: AEI-Brookings Joint Center for Regulatory Studies. Wong, C. H. 2007. Focus: Development of the biotechnology and pharmaceutical industry in Taiwan (The report on the monthly meeting of the presidential palace). Taiwan Economic Forum, 5 (8): 3-23. （翁啟惠，2007，政策焦點：生技製 藥產業在台灣的發展（2007年7月總統府月會專題報告），台灣經濟論衡， 5卷8期：3-23。） Wu, Y. 2005. The effects of state R&D tax credits in simulating private R&D expenditure: A cross-state empirical analysis. Journal of Policy Analysis and Management, 24 (4): 785-802. Yang, C. H., Huang, C. H., and Hou, T. C. T. 2012. Tax incentives and R&D activity: Firm-level evidence from Taiwan. Research Policy, 41 (9): 1578-1588.
RkJQdWJsaXNoZXIy ODg3MDU=